Systemic mastocytosis: A rare cause of osteoporosis and its response to bisphosphonate treatment

Annals of the Rheumatic Diseases

Volumn 64, Issue 6, 2005, Pages 965-966

  Lim, A Y N ^a,b   Ostor, A J K ^a   Love, S ^a   Crisp, A J ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; PAMIDRONIC ACID;

ADULT; AGED; ARTICLE; BONE DENSITY; CELL PROLIFERATION; CLINICAL ARTICLE; FEMALE; HIP; HUMAN; LUMBAR SPINE; MALE; MAST CELL; OSTEOPOROSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SYSTEMIC MASTOCYTOSIS; TREATMENT OUTCOME;

ADULT; AGED; DIPHOSPHONATES; FEMALE; HUMANS; MALE; MASTOCYTOSIS, SYSTEMIC; MIDDLE AGED; OSTEOPOROSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 19544379538     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2004.029116     Document Type: Article

References (9)

1. Cundy T, Beneton MNC, Darby AJ, Marshall WJ, Kanis JA. Osteopenia in systemic mastocytosis: natural history and responses to treatment with inhibitors of bone resorption. Bone 1987;8:149-55.
2. Marshall A, Kavanagh T, Crisp M. The effect of pamidronate on lumbar spine bone density and pain in osteoporosis secondary to systemic mastocytosis. Br J Rheumatol 1997;36:393-6.
3. Brumsen C, Hamdy NAT, Papapoulos SE. Osteoporosis and bone marrow mastocytosis: dissociation of skeletal responses and mast cell activity during long term bisphophonate therapy. J Bone Miner Res 2002;17:567-9.
4. Valent P, Horny H-P, Escribano L, Longley BJ, Li CY, Schwartz LB, et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res 2001;25:603-25.
5. Sperr WR, Jordan J-H, Fiegl M, Escribano L, Bellas C, Dirnhofer S, et al. Serum tryptase levels in patients with mastocytosis: correlation with most cell burden and implication for defining the category of disease. Int Arch Allergy Immunol 2002;128:136-41.
6. Chines A, Pacifici R, Avioli LV, Teitelbaum SL, Korenblat PE. Systemic mastocytosis presenting as osteoporosis: a clinical and histomorphometric study. J Clin Endocrinol Metab 1991;72:140-4.
7. Delling G, Ritzel H, Werner M. Histological characteristics and prevalence of secondary osteoporosis in systemic mastocytosis. A retrospective analysis 158 cases. Pathologe 2001;22:132-40.
8. Russell RG, Rogers MJ. Bisphosphonates: from the laboratory to the clinic and back again. Bone 1999;25:97-106.
9. Johnstone PAS, Mican JM, Metcalfe DD, Delaney TF. Radiotherapy of refractory bone pain due to systemic mast cell disease. Am J Clin Oncol 1994;17:328-30.